Oncologic Emergencies Flashcards
Tumor Lysis Syndrome :
- Whats elevated in the blood and what’s decreased?
- What are some clinical abnormalities?
- Elevated : Potassiium , phosphorus, uric acid
decr : calcium - Kidney injury and failure
-abnormal heart rhythms
-muscle cramps and weakness
-seizures
what are some pt related RF’s for TLS? (7)
What are some disease related rf’s ? (7)
- Exog potassium
- pre existing renal failure
- dehyration/volume depletion
- preexisting hyperuricemia (> 7.5 mg/dL)
- acidic urine
- hypotension
- exposure to nephrotoxins
- Intensity of initial anticancer therapy
- Cancer cell sensitivity to chemotx
- high rate of cancer cell proliferation
- extensive metastasis
- bulky tumors
- WBC > 25 x 10^9
- Elevated LDH : > 2x ULN
What are some characteristic findings of TLS? (4)
HYPERuricemia,kalemia, phosphatemia
HYPOcalcemia
Signs and Sx’s of :
1. Hyperuricemia (1)
2. Hyperkalemia (6)
3. Hyperphosphatemia (3)
4. Hypocalcemia(3)
- Acute renal impairmet or failure
- Muscle weakness, paresthesias, ventricular tachycardia, fibrillation
-cardiac arrest
-lethargy
-N/V - N/V/D
- lethargy or seizures (severe cases)
-Calcium phosphorous precipitation - Cardiac arrhythmias, muscle cramps, tetany , hypotension
TLS definition
1. Uric acid thats ?
2. Potassium ?
3. Phosphorous?
4. Calcium ?
- > = 8 mg/dL or 25% incr from baseline
- > = 6 mg/dL or 25% incr from baseline
- > =4.5 mg/dL or 25% incr from baseline
- <= 7 mg/dL or 25% decr from baseline
TLS Risk Stratification Acute Leukemias : HRD
- ACute myeloid leukemia with WBC _____
- ACute lymphoblastic leukemia with WBC ___ or WBC ___ + LDH ____
- Burkitt Lymphoma / Leukemia in which stage?
- If the burkitt lymph/leuk is in early stage, what does the LDH have to be to make it HRD?
- > = 100 x 10^9 /L
- > = 100 x 10^9 /L
< 100 x 10^9 /L , >=2x ULN - advanced stage
- LDH >=2xULN
Algorithm for Prevention and TX of TLS :
- Low risk
- Intermediate RISK
- High risk
- Clinical judgememt and monitor
- Hydration + initial management with allopurinol (rasburicase may be considered in initial management of pediatric pt’s)
- If hyperuricemia develops–> initiate rasburicase tx - Hydration + initial management with rasburicase
TLS PREVENTION :
-Monitoring, Hydration, Allopurinol, Rasburicase
- Low risk
- Intermed Risk
- High risk
- What would be a CI to rasburicase?
- monitoring, oral hydration, +/- allopurinol
- monitoring, hydration +/- loop diuretic, YES allopurinol
- Monitoring, hydration +/- loop diuretic, YES allopurinol if CI to rasburicase due to G6PD deficiency, yes rasburicase
TLS Prevention :
1. When should u start it?
2. Eliminate ___
3. Hydration amount ? urine output?
4. What can be used to promote diuresis if necessary?
5. Why is sodium bicarb not recc anymore to promote urinary alkalinization ?
- ideally 24-48 hrs prior to chemotherapy initiation
- pharmacotherapy that may contribute to electrolyte abnorms
- 2-3L/m^2/day of IV fluids w/urine output of 80-100 mL/m^2/hr
- Loop diuretics
- no evidence of efficacy and may potentiate risk of calcium phos precipitation
TLS TREATMENT :
1. Pt’s who present with or develop TLS during therapy need continuous ____, frequent (q4-6hr) monitoring of ? (3)
- IV hydration using what?
- CAn use ___ to facilitate urinary excretion of uric acid and electrolytes
- R
- cardiac monitoring
- electrolytes, Scr/BUN, uric acid - Normal saline (2-3 L/m^2/day) for urine output of 100 mL/hr
- Loop diuretics
- Rasburicase
Electrolyte Abnormalities :
- HYPERphosphatemia
Moderate >6 mg/dL restrict ___ and admin of ___
Severe : ____ - HYPOcalcemia :
Calcium < 7 or ionized calcium < 0.8
Asx –> ___
Symptomatic –> ____ - Hyperkalemia :
Moderate and asx (6-7 mEQ/L) should restrict ___, perform ____ and ___ monitoring? and can admin ____
Severe and or symptomatic (>7) –> follow regimen above … what to add if EKG changes? (4)
- Uremia (renal dysfunction) –> ____ and ___ management, how to adjust meds?
- phosphorous intake, phosphate binder ( sevelamer, lanthanum carb, calcium acetate, calcium carbonate, aluminum hydroxide)
- Dialysis - no therapy
- calcium gluconate 1 gram with EKG monitoring - K+ intake, EKG, cardiac rhythm, sodium polystyrene sulfonate 15-30 g PO repeat q4-6 h
- calcium gluconate, IV insulin + dextrose, sodium bicarb, albuterol
- Fluid electrolyte, uric acid + phosphate, renally adjust
Allopurinol :
1. Dosing ?
2. Whats the prophylactic option for medium risk ?
3. Signif dose adjustments for ___/____ required when used concurrently ?
- 100mg/M^2/dose every 8 hrs or 10mg/kg/day divided every 8hrs PO
Max : 800 mg/day
200-400 mg/m^2/day IV in 1-3 divided doses IV
Max : 600 mg/day
- 300 mg PO daily renally adjusted if necessary. Initiate 24-48 hrs before chemotx and continue for up to 3-7 days
- 6mercaptopurine/azathioprine
Febuxostat :
1. When do we use it ?
- Advantages
- disadvantages
- Hyperuricemia who cannot tolerate allopurinol in a setting in which rasburicase is either not avail or CI
- dose adjust not needed in pt’s with mild to moderate renal impairment
- fewer DDI’s than allopurinol - more expensive
Rasburicase :
1. Dosing ?
2. What must u do with blood samples?
3. CI in which pt’s ?
- 0.2 mg/kg daily x 5 days (FDA)
-Clinical practice : 3 mg X 1 dose, repeat if clinically indicated - place on ice
- G6PD deficient pt’s
HYPERcalcemia of Malignancy Signs/Sx’s :
- Neuro and psychiatric
- GI (ACAN)
- Cardio (AHIIS)
- Renal (PPDHHH)
- Lethargy, drowsy, confusion, delirium, hypotonia, decr deep tendon reflexes , coma
- anorexia , constipation, N/V, Abd pain
- Arrhythmias, HTN, incr myocard contractility, incomplete AV block , shortened QT interval
- Polyuria, polydipsia, dehydration , HYPO natremia, magnesemia, kalemia